Internal Medicine, Hematology & Oncology · Dublin, GA
NPI
1316938848
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
207 Fairview Park Dr
Dublin, GA, 31021
Phone (478) 275-1111
Groups this clinician bills Medicare through
Medicare paid, 2024
$566K
42,078 services
Medicare patients, 2024
126
Average age 74
Drug cost, 2024
$1.3M
580 prescriptions
Company payments, 2025
$952
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marco A Ayulo Sr. was code J0897 (injection, denosumab, 1 mg), 3,180 times for 21 patients. In total Marco A Ayulo Sr. billed 42,078 services in 64 codes, and Medicare paid $566K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 3,180 | 21 | $20.21 | $64K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,898 | 24 | $0.09 | $168 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,220 | 14 | $0.07 | $87.09 |
| 85025 Blood Count | Office | 527 | 122 | $7.61 | $4,010 |
| 99214 Office E&M - Established | Office | 326 | 110 | $87.45 | $29K |
| 96367 Intravenous Infusion, Hydration | Office | 316 | 24 | $19.85 | $6,271 |
| 96366 Intravenous Infusion, Hydration | Office | 266 | 15 | $14.11 | $3,752 |
| 96365 Intravenous Infusion, Hydration | Office | 227 | 21 | $42.36 | $9,615 |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 166 | 12 | $2.01 | $333 |
| 96372 Injection Administration | Office | 144 | 33 | $10.23 | $1,473 |
| 36415 Venipuncture Blood Collection | Office | 125 | 71 | $8.65 | $1,081 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 118 | 15 | $1.02 | $121 |
| 96413 Chemotherapy Administration | Office | 108 | 15 | $89.49 | $9,665 |
| 96375 Injection Administration | Office | 87 | 15 | $10.69 | $930 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 81 | 11 | $0.66 | $53.3 |
By year: 2022 $477K for 18,013 services; 2023 $372K for 41,470 services; 2024 $566K for 42,078 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 527 | 122 | $7.61 | $4,010 |
| 36415 Venipuncture Blood Collection | 125 | 71 | $8.65 | $1,081 |
Medicare prescription drug claims, 2024
In 2024, the drug Marco A Ayulo Sr. prescribed most often to Medicare patients was Letrozole, with 87 prescriptions and refills. In total Marco A Ayulo Sr. wrote 580 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 87 | 152 | 23 | $1,548 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 40 | 45 | Under 11 | $155K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 33 | 33 | Under 11 | $918 |
| Dexamethasone Sodium Phosphate Generic | 29 | 29 | Under 11 | $58.31 |
| Pantoprazole Sodium Generic | 29 | 39 | Under 11 | $188 |
| Anastrozole Generic | 25 | 36 | Under 11 | $210 |
| Diphenhydramine Hcl Generic | 24 | 24 | Under 11 | $45.32 |
| Levothyroxine Sodium Generic | 17 | 31 | Under 11 | $147 |
| Oxycodone Hcl Generic | 15 | 15 | Under 11 | $306 |
| Xgeva Denosumab | 12 | 12 | Under 11 | $39K |
| Lenalidomide Generic | 12 | 12 | Under 11 | $121K |
| Gabapentin Generic | 12 | 12 | Under 11 | $392 |
| Kisqali Ribociclib Succinate | 12 | 12 | Under 11 | $208K |
| Enhertu Fam-Trastuzumab Deruxtecn-Nxki | 11 | 11 | Under 11 | $150K |
Brand drugs: 164 claims; generic drugs: 416 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marco A Ayulo Sr. $952 ($952 in general payments such as food, travel and fees) from 21 companies. The largest payer was Astellas Pharma US Inc with $187.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 5 | $187 |
| Merck Sharp & Dohme LLC MRK | 5 | $128 |
| Janssen Biotech, Inc. JNJ | 3 | $67.22 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $53.54 |
| Lilly USA, LLC LLY | 3 | $49.14 |
| Incyte Corporation INCY | 3 | $48.52 |
| Celgene Corporation BMY | 2 | $45.53 |
| Daiichi Sankyo Inc. 4568.T | 2 | $44.48 |
| BeOne Medicines USA, Inc. ONC | 2 | $44.1 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $43.72 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.